Cheng C, Ye L, Zuo Y, Wang Y, Wang L, Li F
Antioxidants (Basel). 2024; 13(10).
PMID: 39456503
PMC: 11505429.
DOI: 10.3390/antiox13101250.
Demirtas Inci S, Gunduz H, Gunduz Y
Biomark Med. 2024; 18(8):399-406.
PMID: 39041846
PMC: 11285231.
DOI: 10.1080/17520363.2024.2345582.
Fu Y, Wu Y, Liu E
Exp Ther Med. 2020; 20(2):1211-1219.
PMID: 32765664
PMC: 7388508.
DOI: 10.3892/etm.2020.8840.
Jin Z, Chen Y, Weng X, Huang A, Lin S, Li H
J Int Med Res. 2020; 48(5):300060520904835.
PMID: 32389049
PMC: 7221173.
DOI: 10.1177/0300060520904835.
de Carvalho S, Simoes E Silva A, Sabino A, Evangelista F, Gomes K, Dusse L
PLoS One. 2016; 11(3):e0150613.
PMID: 27022914
PMC: 4811575.
DOI: 10.1371/journal.pone.0150613.
Association between inflammatory biomarkers and thin-cap fibroatheroma detected by optical coherence tomography in patients with coronary heart disease.
Koyama K, Yoneyama K, Mitarai T, Ishibashi Y, Takahashi E, Kongoji K
Arch Med Sci. 2015; 11(3):505-12.
PMID: 26170842
PMC: 4495146.
DOI: 10.5114/aoms.2015.52352.
Early inflammatory markers are independent predictors of cardiac allograft vasculopathy in heart-transplant recipients.
Labarrere C, Woods J, Hardin J, Jaeger B, Zembala M, Deng M
PLoS One. 2014; 9(12):e113260.
PMID: 25490200
PMC: 4260824.
DOI: 10.1371/journal.pone.0113260.
Protective effects of chinese traditional medicine buyang huanwu decoction on myocardial injury.
Yang G, Fang Z, Liu Y, Zhang H, Shi X, Ji Q
Evid Based Complement Alternat Med. 2009; 2011:930324.
PMID: 19204010
PMC: 3138753.
DOI: 10.1093/ecam/nep013.
Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings.
Madan M, Amar S
PLoS One. 2008; 3(9):e3204.
PMID: 18787704
PMC: 2527517.
DOI: 10.1371/journal.pone.0003204.
Peroxisome proliferator-activated receptors in the modulation of the immune/inflammatory response in atherosclerosis.
Fernandez A
PPAR Res. 2008; 2008:285842.
PMID: 18769491
PMC: 2519138.
DOI: 10.1155/2008/285842.
Role of leptin in atherogenesis.
Dubey L, Hesong Z
Exp Clin Cardiol. 2008; 11(4):269-75.
PMID: 18651016
PMC: 2274849.
C-reactive protein is expressed and secreted by peripheral blood mononuclear cells.
Haider D, Leuchten N, Schaller G, Gouya G, Kolodjaschna J, Schmetterer L
Clin Exp Immunol. 2006; 146(3):533-9.
PMID: 17100775
PMC: 1810406.
DOI: 10.1111/j.1365-2249.2006.03224.x.
Physical activity and high-sensitivity C-reactive protein.
Plaisance E, Grandjean P
Sports Med. 2006; 36(5):443-58.
PMID: 16646631
DOI: 10.2165/00007256-200636050-00006.
Associations between C-reactive protein and circulating cell adhesion molecules in patients with unstable angina undergoing coronary intervention and their clinical implication.
Doo Y, Han S, Park W, Kim S, Choi S, Cho G
Clin Cardiol. 2005; 28(1):47-51.
PMID: 15704532
PMC: 6654017.
DOI: 10.1002/clc.4960280112.
Anti-inflammatory strategies in hypertension: focus on COX-1 and COX-2.
Hermann M, Enseleit F, Ruschitzka F
Curr Hypertens Rep. 2005; 7(1):52-60.
PMID: 15683587
DOI: 10.1007/s11906-005-0055-7.
Increased mortality in depressive disorders: a review.
Cuijpers P, Schoevers R
Curr Psychiatry Rep. 2004; 6(6):430-7.
PMID: 15538991
DOI: 10.1007/s11920-004-0007-y.
Raised concentrations of macrophage colony stimulating factor in severe unstable angina beyond the acute phase are strongly predictive of long term outcome.
Rallidis L, Zolindaki M, Pentzeridis P, Poulopoulos K, Velissaridou A, Apostolou T
Heart. 2003; 90(1):25-9.
PMID: 14676235
PMC: 1768029.
DOI: 10.1136/heart.90.1.25.
Prognostic value of C-reactive protein, fibrinogen, interleukin-6, and macrophage colony stimulating factor in severe unstable angina.
Rallidis L, Zolindaki M, Manioudaki H, Laoutaris N, Velissaridou A, Papasteriadis E
Clin Cardiol. 2002; 25(11):505-10.
PMID: 12430780
PMC: 6654719.
DOI: 10.1002/clc.4960251106.
Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia.
Keating G, Ormrod D
Drugs. 2002; 62(13):1909-44.
PMID: 12215067
DOI: 10.2165/00003495-200262130-00013.
